Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-017519

President and CEO gave up 47,774 shares (to pay taxes)

  • President and CEO acquired 114,403 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2021-03-01 Option exercise +96,150 1,251,948 D: show line 1 in the form
Walker Neal President and CEO 2021-03-01 Shares withheld for taxes −39,792 $24.06 $957,396 1,212,156 D: show line 2 in the form
Walker Neal President and CEO 2021-03-02 Option exercise +18,253 1,230,409 D: show line 3 in the form
Walker Neal President and CEO 2021-03-02 Shares withheld for taxes −7,982 $23.25 $185,582 1,222,427 D: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2021-03-01 Grant or award · Employee Stock Option (Right to Buy) +255,800 255,800 D: show line 5 in the form
Walker Neal President and CEO 2021-03-01 Grant or award · Restricted stock units +73,100 73,100 D: show line 6 in the form
Walker Neal President and CEO 2021-03-01 Option exercise · Restricted stock units −96,150 192,300 D: show line 7 in the form
Walker Neal President and CEO 2021-03-02 Option exercise · Restricted stock units −18,253 54,762 D: show line 8 in the form
Loading xslF345X03/doc4.xml…